Long-term outcome in fetuses with cardiac arrhythmias

Obstetrics and Gynecology

Volumn 102, Issue 6, 2003, Pages 1372-1379

  Boldt, Talvikki ^a   Eronen, Marianne ^a   Andersson, Sture ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT;

ANTIARRHYTHMIC ACTIVITY; ARTICLE; ATRIOVENTRICULAR BLOCK; CONGENITAL HEART MALFORMATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DATA ANALYSIS; DISEASE CLASSIFICATION; FEMALE; FETUS; FETUS DISEASE; FETUS MONITORING; FOLLOW UP; HEART ARRHYTHMIA; HEART VENTRICLE EXTRASYSTOLE; HUMAN; INCIDENCE; MALE; NEUROLOGIC DISEASE; OUTCOMES RESEARCH; PERINATAL MORBIDITY; PERINATAL MORTALITY; PRIORITY JOURNAL; SINUS BRADYCARDIA; SUPRAVENTRICULAR PREMATURE BEAT; SUPRAVENTRICULAR TACHYCARDIA; SURVIVAL RATE; TREATMENT INDICATION;

EID: 0344687423     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.obstetgynecol.2003.08.019     Document Type: Article

References (32)

1. Simpson L.L. Fetal supraventricular tachycardias Diagnosis and management . Semin Perinatol. 24:2000;5. :360-72.
2. Allan L.D., Hornberger L., Sharland G. Textbook of fetal cardiology. 2000;423-431 Greenwich Medical Media, London.
3. Simpson J.M., Sharland G.K. Fetal tachycardias Management and outcome in 127 consecutive cases . Heart. 79:1998;576-581.
4. Groves A.M.M., Alland L.D., Rosenthal E. Outcome of isolated congenital heart block diagnosed in utero. Heart. 75:1998;190-194.
5. Eronen M., Heikkilä P., Teramo K. Congenital complete heart block in the fetus Hemodynamic features, antenatal treatment, and outcome in six cases . Pediatr Cardiol. 22:2001;385-392.
6. Reed K.L., Sahn D.J., Marx G.R., Andersson C.F., Shenker L. Cardiac Doppler flows during fetal arrhythmias Physiological consequences . Obstet Gynecol. 79:1987;1-6.
7. Eronen M. Outcome of fetuses with heart disease diagnosed in utero. Arch Dis Child. 77:1997;F41-46.
8. Maxwell D., Crawford D., Curry P., Tynan M., Allan L. Obstetric importance, diagnosis and management of fetal tachycardias. BMJ. 297:1988;107-110.
9. Flack N.J., Zosmer N., Bennet P.R., Vaughan J., Fisk N.M. Amiodarone given by three routes to terminate fetal atrial flutter associated with severe hydrops. Obstet Gynecol. 82:1993;713-716.
10. Kleinman C.S., Copel J.A., Weinstein E.M., Santulli T.V., Hobbins J.C. In utero diagnosis and treatment of fetal supraventricular tachycardia. Semin Perinatol. 9:1985;2. 113-29.
11. Simpson J.M., Yates R.W., Sharland G.K. Irregular heart rate in the fetus - Not always benign. Cardiol Young. 6:1996;28-31.
12. Copel J.A., Liang R.I., Demasio K., Ozeren S., Kleinman C.S. The clinical significance of the irregular fetal heart rhythm. Am J Obstet Gynecol. 182:2000;813-819.
13. Allan L.D. Fetal cardiology. Curr Opin Obstet Gynecol. 8:1996;142-147.
14. Simpson L.L., Marx G.R. Diagnosis and treatment of structural fetal cardiac abnormality and dysrhythmia. Semin Perinatol. 18:1994;3. :215-27.
15. Meijboom E.J., van Engelen A.D., van de Beek E.W., Weijtens O., Lautenschutz J.M., Avraham A.B. Fetal arrhythmias. Curr Opin Cardiol. 9:1994;97-102.
16. van Engelen A.D., Weijtens O., Breener J.I. Management, outcome and follow up of fetal tachycardia. J Am Coll Cardiol. 24:1994;1371-1375.
17. Sonesson S.E., Fouron J.C., Wesslen-Ericsson E. Fetal supraventricular tachycardia treated with sotalol. Acta Paediatr. 87:1998;584-587.
18. Hansman M., Gembruch U., Bald R., Redel Manz M. Fetal tachyarrhythmias Transplacental and direct treatment of the fetus - A report of sixty cases . Ultrasound Obstet Gynecol. 1:1991;162-170.
19. Hallak M., Neerhof M.G., Perry R. Fetal supraventricular tachycardia and hydrops fetalis Combined intensive, direct and transplacental therapy . Obstet Gynecol. 78:1991;523-525.
20. Lethor J.-P., de Moor M. Multiple cardiac tumors in the fetus. Circulation. 103:2001;55.
21. Frohn-Muller I.M., Stewart P.A., Witsenburg M. The efficacy of flecainide versus digoxin in the management of fetal supraventricular tachycardia. Prenatal Diagn. 15:1995;1297-1302.
22. Benson D.W., Dunnigan A., Bendit D.G. Follow up evalution of infant paroxysmal atrial tachycardia Transeosophageal study . Circulation. 75:1987;542-549.
23. Sonesson S.E., Winberg P., Lidegran M., Westgren M. Fetal supraventricular tachycardia and cerebral complications. Acta Pediatr. 85:1996;1249-1252.
24. Schade R.P., Stouteenbeek P., de Vries K. Neurological morbidity after fetal supraventricular tachycardia. Ultrasound Obstet Gynecol. 13:1999;43-47.
25. Julkunen H., Eronen M. Long term outcome of mothers of children with congenital heart block in Finland. Arthritis Rheum. 44:2001;647-652.
26. Schmidt K.G., Ulmer H.E., Silverman N.H., Kleinman C.S., Copel J.A. Perinatal outcome of fetal complete atrioventricular block A multicenter experience . J Am Coll Cardiol. 17:1991;1360-1366.
27. Eronen M., Siren M.K., Ekblad H., Tikanaja T., Julkunen H., Paavilainen T. Short and long term outcome of the children with isolated complete heart block diagnosed in utero or as a newborn. Pediatrics. 106:2000;86-91.
28. Buyon J., Hiebert R., Copel J. Autoimmune-associated congenital heart block Demographics, mortality, morbidity and recurrence rates obatained from a national neonatal lupus registry . J Am Coll Cardiol. 31:1998;1658-1666.
29. Anandakumar C., Biswas A., Chew S.S. Direct fetal therapy for hydrops secondary to congenital atrioventricular heart block. Obstet Gynecol. 87:1996;835-837.
30. Yamada H., Kato E.H., Ebina Y. Fetal treatment of congenital heart block ascribed to anti-SSA antibody A case reports with observation of cardiohemodynamics and review of the literature . Am J Reprod Immunol. 42:1999;226-232.
31. Machado M.V., Tynan M.J., Durry P.V., Allan L.D. Fetal complete heart block. Br Heart J. 60:1988;512-515.
32. Hofbeck M., Ulmer H., Beinder E., Sieber E., Singer H. Prenatal findings in patients with prolonged QT interval in the neonatal period. Heart. 77:1997;198-204.